臨床および実験皮膚科学研究ジャーナル
オープンアクセス

概要

Granuloma Annulare in the Setting of Ipilimumab Therapy

Haselden VN, Vyas R, Koon H and Gerstenblith MR

We present a patient who developed granuloma annulare during ipilimumab therapy. Many adverse events of ipilimumab therapy are well documented, such as rash, colitis, hepatotoxicity, and endocrinopathies [1]. Here, we describe a case of granuloma annulare as a side effect of ipilumumab therapy.